Windjammer Capital Acquires Bio X Cell

WindRose Health Investors Recapitalizes Lykan Bioscience Holdings

June 4, 2019

Biotechnology

WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.

Windjammer Capital Acquires Compex Legal Services

February 1, 2020

Professional Services

Windjammer Capital Investors has acquired Compex Legal Services, a tech-enabled provider of outsourced medical records retrieval and litigation support, in a transaction with management. Windjammer said it will support Compex's next phase of growth through technology investments and complementary acquisitions.

Astellas Pharma Acquires Xyphos Biosciences

December 26, 2019

Biotechnology

Astellas Pharma has acquired Xyphos Biosciences, gaining Xyphos' ACCEL convertible-CAR technology platform and immuno-oncology talent. The deal included $120 million paid at closing and potential milestone payments bringing the total transaction value to up to $665 million.

Windjammer Capital Acquires Hilco Vision

September 10, 2019

Healthcare Services

Windjammer Capital Investors has acquired Hilco Vision (The Hilsinger Company) in partnership with Hilco management; terms were not disclosed. Windjammer positions Hilco as a platform investment to accelerate growth through organic initiatives and strategic acquisitions in the eyecare/optical distribution market.

Bio-Techne Acquires Namocell

June 22, 2022

Medical Devices

Bio-Techne Corporation has agreed to acquire Namocell, Inc., a Mountain View–based provider of single-cell sorting and dispensing platforms, with the deal expected to close in Bio-Techne's fiscal 2023 Q1. Namocell's Pala and Hana systems (installed base approaching 200 placements, ~60 sold in 2021) will complement Bio-Techne's Cell and Gene Therapy franchise and create commercial synergies across its analytical instruments sales force.

Patricia Industries (Investor AB) Acquires Advanced Instruments from Windjammer Capital

September 1, 2020

Medical Devices

Patricia Industries, part of Investor AB, has signed an agreement to acquire Advanced Instruments, LLC from Windjammer Capital for an enterprise value of $780 million. Advanced Instruments, headquartered in Norwood, Massachusetts, is a manufacturer of scientific and analytical instruments serving the clinical, biotechnology and food & beverage markets; the transaction is expected to close in Q4 2020 subject to regulatory approvals.